CLINICAL OUTCOME ACCORDING TO ENDOSCOPIC EVALUATION OF NEOADJUVANT CHEMOTHERAPY AND PATHOLOGICAL TUMOR REGRESSION GRADE IN RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA.

(2) Department of Gastroenterology, Endoscopy Division,National Cancer Center Hospital East,Kashiwa,Japan

(3) Department of Pathology Division, Research Center for Innovative Oncology,National Cancer Center Hospital East,Kashiwa,Japan

(4) Department of Gastroenterology, Oncology Division,National Cancer Center Hospital East,Kashiwa,Japan

(5) Department of Esophageal surgery,National Cancer Center Hospital East,Kashiwa,Japan



This item was part of UEG Week 2015

This item can be cited as: United European Gastroenterology Journal; 2015: 2 (Supplement 1)